Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:APHA NYSE:BHC NASDAQ:CRON NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphriaC$0.00C$3.93▼C$40.93C$5.24BN/A6.16 million shs9.61 million shsBHCBausch Health Cos$4.86-1.5%$5.10$4.57▼$8.69$1.82B0.422.12 million shs1.23 million shsCRONCronos Group$2.79+1.5%$2.74$1.92▼$3.43$1.04B0.891.33 million shs745,202 shsPBHPrestige Consumer Healthcare$49.92-1.3%$47.96$42.62▼$77.45$2.36B0.35564,774 shs443,129 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos+1.23%+1.85%-0.20%-16.40%-23.23%CRONCronos Group+0.36%-1.08%+5.77%+2.23%+36.82%PBHPrestige Consumer Healthcare+4.54%+4.41%+6.50%-12.72%-32.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphriaC$0.00C$3.93▼C$40.93C$5.24BN/A6.16 million shs9.61 million shsBHCBausch Health Cos$4.86-1.5%$5.10$4.57▼$8.69$1.82B0.422.12 million shs1.23 million shsCRONCronos Group$2.79+1.5%$2.74$1.92▼$3.43$1.04B0.891.33 million shs745,202 shsPBHPrestige Consumer Healthcare$49.92-1.3%$47.96$42.62▼$77.45$2.36B0.35564,774 shs443,129 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos+1.23%+1.85%-0.20%-16.40%-23.23%CRONCronos Group+0.36%-1.08%+5.77%+2.23%+36.82%PBHPrestige Consumer Healthcare+4.54%+4.41%+6.50%-12.72%-32.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/ABHCBausch Health Cos 1.80Reduce$8.0064.78% UpsideCRONCronos Group 2.20Hold$2.30-17.56% DownsidePBHPrestige Consumer Healthcare 2.00Hold$70.7541.72% UpsideCurrent Analyst Ratings BreakdownLatest CRON, APHA, PBH, and BHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2026PBHPrestige Consumer Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/18/2026PBHPrestige Consumer Healthcare Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/15/2026PBHPrestige Consumer Healthcare Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$86.00 ➝ $72.005/14/2026PBHPrestige Consumer Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/14/2026PBHPrestige Consumer Healthcare OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/7/2026PBHPrestige Consumer Healthcare OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$77.00 ➝ $65.005/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)4/27/2026BHCBausch Health Cos Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$10.00 ➝ $9.004/21/2026PBHPrestige Consumer Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 7/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphriaC$611.06M0.00N/A22.40C$4.76 per share0.00BHCBausch Health Cos$10.27B0.18$7.25 per share0.67$1.02 per share4.76CRONCronos Group$146.59M7.10$0.01 per share218.55$3.00 per share0.93PBHPrestige Consumer Healthcare$1.09B2.17$5.37 per share9.29$39.89 per share1.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphriaN/A-C$2.01N/AN/AN/AN/AN/AN/AN/ABHCBausch Health Cos$157M-$3.24N/A1.33N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)CRONCronos Group-$9.45M$0.01279.28N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)PBHPrestige Consumer Healthcare$190.30M$3.9112.7710.581.5517.48%11.54%6.16%8/6/2026 (Estimated)Latest CRON, APHA, PBH, and BHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026CRONCronos Group$0.01N/AN/AN/A$44.20 millionN/A8/6/2026Q1 2027PBHPrestige Consumer Healthcare$0.89N/AN/AN/A$249.68 millionN/A7/29/2026Q2 2026BHCBausch Health Cos$0.96N/AN/AN/A$2.56 billionN/A5/13/2026Q4 2026PBHPrestige Consumer Healthcare$1.39$1.23-$0.16$1.13$293.64 million$281.62 million5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$45.21 million4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/ABHCBausch Health CosN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/APBHPrestige Consumer Healthcare$1.903.81%N/A48.59%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria59.293.371.63BHCBausch Health Cos54.681.320.97CRONCronos GroupN/A21.8720.73PBHPrestige Consumer Healthcare0.543.572.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphriaN/ABHCBausch Health Cos78.65%CRONCronos Group8.71%PBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/ABHCBausch Health Cos20.67%CRONCronos Group7.80%PBHPrestige Consumer Healthcare1.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/ANot OptionableBHCBausch Health Cos20,300374.03 million296.72 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionablePBHPrestige Consumer Healthcare54047.37 million46.66 millionOptionableCRON, APHA, PBH, and BHC HeadlinesRecent News About These CompaniesJohn Rogers Increases Stake in Prestige Consumer Healthcare IncJuly 13, 2026 | gurufocus.comPrestige Consumer Healthcare Inc. $PBH Stake Lessened by New York State Teachers Retirement SystemJuly 12, 2026 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of "Hold" by AnalystsJuly 12, 2026 | americanbankingnews.comIs the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?July 6, 2026 | zacks.comPrestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results DateJuly 6, 2026 | globenewswire.comPrestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand AcquisitionJuly 4, 2026 | finance.yahoo.comSG Americas Securities LLC Has $1.19 Million Stock Holdings in Prestige Consumer Healthcare Inc. $PBHJuly 4, 2026 | marketbeat.comPrestige Consumer Healthcare Inc. $PBH Shares Sold by Boston Trust Walden CorpJuly 4, 2026 | marketbeat.comPrestige Consumer Healthcare Announces Proposed Private Offering of $400 Million Senior Notes Due 2034 to Redeem 2028 NotesJune 30, 2026 | quiverquant.comQPrestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior NotesJune 30, 2026 | globenewswire.comPrestige Consumer Healthcare Inc. ($PBH) Chair, President, and CEO 2026 Pay RevealedJune 29, 2026 | quiverquant.comQPrestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS InvestigatingJune 25, 2026 | prnewswire.comPrestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, Hagens Berman InvestigatingJune 23, 2026 | globenewswire.comDean Capital Management Takes $2.52 Million Position in Prestige Consumer Healthcare Inc. $PBHJune 19, 2026 | marketbeat.comPrestige Consumer Healthcare Inc. $PBH Shares Sold by Aristotle Capital Boston LLCJune 18, 2026 | marketbeat.comPrestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®June 15, 2026 | globenewswire.comDoes Earnings Miss, Weaker Outlook and Probe Into Disclosures Change The Bull Case For PBH?June 14, 2026 | finance.yahoo.comWhy is Prestige Consumer Healthcare (PBH) up 3.6% since last earnings report?June 12, 2026 | msn.comPBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law FirmJune 11, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBHJune 11, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBHJune 9, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Apple Just Handed These 4 Memory Stocks Their Best News of the YearBy Bridget Bennett | June 28, 2026Is the Memory Rally Still Alive After the Semiconductor Sell-Off?By Jessica Mitacek | July 2, 2026Micron’s HBM Surge Could Redefine the AI Growth StoryBy Thomas Hughes | June 25, 2026CRON, APHA, PBH, and BHC Company DescriptionsAphria TSE:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Bausch Health Cos NYSE:BHC$4.86 -0.08 (-1.52%) Closing price 03:59 PM EasternExtended Trading$4.80 -0.06 (-1.22%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Cronos Group NASDAQ:CRON$2.79 +0.04 (+1.45%) Closing price 04:00 PM EasternExtended Trading$2.80 +0.01 (+0.36%) As of 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Prestige Consumer Healthcare NYSE:PBH$49.92 -0.68 (-1.34%) Closing price 03:59 PM EasternExtended Trading$49.92 +0.00 (+0.00%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector GE Aerospace Faces a Prove-It Moment in Q2 Earnings Sandisk: What the Chart Is Trying to Tell Us Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? 3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
